A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Dexcom Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 547,946 shares of DXCM stock, worth $44 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
547,946
Previous 389,000 40.86%
Holding current value
$44 Million
Previous $44.1 Million 16.74%
% of portfolio
0.07%
Previous 0.08%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $10.2 Million - $18.4 Million
158,946 Added 40.86%
547,946 $36.7 Million
Q2 2024

Aug 14, 2024

SELL
$110.31 - $140.45 $8.84 Million - $11.3 Million
-80,160 Reduced 17.09%
389,000 $44.1 Million
Q1 2024

May 15, 2024

SELL
$114.22 - $140.1 $12.1 Million - $14.9 Million
-106,140 Reduced 18.45%
469,160 $65.1 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $14.3 Million - $23.6 Million
189,700 Added 49.2%
575,300 $71.4 Million
Q3 2023

Nov 14, 2023

SELL
$86.06 - $137.93 $8.05 Million - $12.9 Million
-93,560 Reduced 19.53%
385,600 $36 Million
Q2 2023

Aug 14, 2023

SELL
$112.47 - $130.98 $24.9 Million - $28.9 Million
-220,958 Reduced 31.56%
479,160 $61.6 Million
Q1 2023

May 15, 2023

SELL
$104.0 - $122.92 $4.45 Million - $5.26 Million
-42,782 Reduced 5.76%
700,118 $81.3 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $15.5 Million - $22.4 Million
182,900 Added 32.66%
742,900 $84.1 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $11.5 Million - $14.2 Million
151,200 Added 36.99%
560,000 $45.1 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $20.9 Million - $40.9 Million
307,625 Added 304.05%
408,800 $30.5 Million
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $197,568 - $273,420
-2,100 Reduced 2.03%
101,175 $51.8 Million
Q4 2021

Feb 14, 2022

SELL
$129.87 - $162.82 $64,935 - $81,410
-500 Reduced 0.48%
103,275 $55.5 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $53,355 - $71,590
-500 Reduced 0.48%
103,775 $56.8 Million
Q2 2021

Aug 16, 2021

BUY
$80.99 - $107.93 $1.42 Million - $1.89 Million
17,500 Added 20.17%
104,275 $44.5 Million
Q1 2021

May 17, 2021

SELL
$84.79 - $104.74 $3.38 Million - $4.17 Million
-39,850 Reduced 31.47%
86,775 $31.2 Million
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $1.52 Million - $2.03 Million
19,456 Added 18.15%
126,625 $46.8 Million
Q3 2020

Nov 16, 2020

BUY
$95.51 - $112.95 $38,204 - $45,180
400 Added 0.37%
107,169 $44.2 Million
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $2.93 Million - $4.93 Million
46,769 Added 77.95%
106,769 $43.3 Million
Q1 2020

May 15, 2020

BUY
$47.79 - $75.63 $2.87 Million - $4.54 Million
60,000 New
60,000 $16.2 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.